Ian W. Flinn, John M. Burke, Jeff Porter Sharman, Bertrand Marquess Anz, Richard Zuniga, Aung M. Tun, Prachi Jani, Juliana M.L. Biondo, Mei Wu, Yong Mun, Vivek S. Chopra, Rona Farighi, Tony Lin, Jose Caetano Villasboas, Lihua Elizabeth Budde. "Fixed duration subcutaneous (SC) mosunetuzumab (Mosun) in patients with previously untreated high-tumor burden follicular lymphoma (FL): Interim results from the phase II MorningSun study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.7014